$2.330
-0.068 (-2.92%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
INMB Prediction & Forecast by Similar Chart Analysis
Alphio's INMB stock price prediction model matches the current INmune Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.32 (-0.31%). The 1-week path is $2.31 (-0.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy INmune Bio Inc Stock?
INmune Bio Inc is a good buy right now due to its recent submission of an Orphan Drug Application for Ebstrocel, which could grant 10 years of market exclusivity, and a significant 95% reduction in Q2 net loss to $1.27 million. The current price of $2.33 is well below the analyst target of $9, suggesting substantial upside. However, the main risk is the company's ongoing net losses, with a net income of -$1.27 million in Q2 2026.
INMB stock price ended at $2.33 on Friday, after losing -2.92%
INmune Bio Inc (INMB) last closed at $2.33, losing -2.92%. These facts feed the 1-day and 1-week INMB price prediction above.
Forecast Drivers
INmune Bio Inc (INMB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches INMB, ranked by similarity.
Seasonality analysis for INMB
Historically the probability of a positive August return for INMB is 32.81%. January offers the highest probability of a positive month at 78.69%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for INMB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $17.95 | $20.82 | $22.70 | +793.72% |
| Sep 2026 | $15.57 | $20.82 | $21.07 | +793.72% |
| Oct 2026 | $11.81 | $20.82 | $23.44 | +793.72% |
| Nov 2026 | $5.83 | $13.91 | $18.90 | +497.01% |
| Dec 2026 | $14.81 | $15.12 | $23.16 | +548.98% |
In 2026, INmune Bio Inc (INMB) is projected to range from $5.83 to $23.44.
INmune Bio Inc 2026 monthly forecast
In Aug 2026, INmune Bio Inc is projected to average $20.82, with a low of $17.95 and high of $22.70.
In Sep 2026, INmune Bio Inc is projected to average $20.82, with a low of $15.57 and high of $21.07.
In Oct 2026, INmune Bio Inc is projected to average $20.82, with a low of $11.81 and high of $23.44.
In Nov 2026, INmune Bio Inc is projected to average $13.91, with a low of $5.83 and high of $18.90.
In Dec 2026, INmune Bio Inc is projected to average $15.12, with a low of $14.81 and high of $23.16.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.